1 |
Wesierska-Gadek J, Krystof V. Selective cyclin-dependent kinase inhibitors discriminating between cell cycle and transcriptional kinases: future reality or utopia? Ann N Y Acad Sci 2009;1171 :228-41.
DOI
ScienceOn
|
2 |
Sherr CJ. The Pezcoller lecture: cancer cell cycles revisited. Cancer Res 2000;60(14):3689-95.
|
3 |
Morgan DO. Principles of CDK regulation. Nature 1995;374(6518):131-4.
DOI
|
4 |
Ortega S, Malumbres M, Barbacid M. Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim Biophys Acta 2002;1602(1):73-87.
|
5 |
Bartek J, Bartkova J, Lukas J. The retinoblastoma protein pathway and the restriction point. Curr Opin Cell Biol 1996;8(6):805-14.
DOI
|
6 |
Helmbold H, Galderisi U, Bohn W. The switch from pRb/p105 to Rb2/p130 in DNA damage and cellular senescence. J Cell Physiol 2012; 227(2):508-13.
DOI
|
7 |
Girard F, Strausfeld U, Fernandez A, Lamb NJ. Cyclin A is required for the onset of DNA replication in mammalian fibroblasts. Cell 1991; 67(6):1169-79.
DOI
|
8 |
Brandeis M, Hunt T. The proteolysis of mitotic cyclins in mammalian cells persists from the end of mitosi until the onset of S phase. EMBO J 1996;15(19):5280-9.
|
9 |
Markers M, Brockow T, Resch KL. Exercise for women receiving adjuvant therapy for breast cancer. Cochrane Database Syst Rev 2006;18(4) :CD005001.
|
10 |
Gøtzsche PC, Nielsen M. Screening for breast cancer with mammography. Cochrane Database Syst Rev 2011;19(1):CD001877.
|
11 |
Lee KS, Shin JS, Nam KS. Cancer chemopreventive effects of starfish polysaccharide in human breast cancer cell. Biotechnol Bioprocess eng 2011;16(5) :987-91.
DOI
|
12 |
Fairey AS, Courneya KS, Field CJ, Mackey JR. Physical exercise and immune system function in cancer survivors: a comprehensive review and future directions. Cancer 2002;94(2):539-51.
DOI
|
13 |
송미선, 김윤상, 임은미. 건칠에 대한 문헌적 고찰. 대한한방부인과학회지 2002;15(1):61-76.
|
14 |
Levine AJ, Hu W, Feng Z. P53 pathway: what questions remain to be explored? Cell Death Differ 2006;13(6):1027-36.
DOI
|
15 |
Vargas DA, Takahashi S, Ronai Z. Mdm2: A regulator of cell growth and death. Adv Cancer Res 2003;89:1-34.
DOI
|
16 |
Komarov PG, Komarova EA, Kondratov RV, Christov-Tselkov K, Coon JS, Chernov MV, Gudkov AV. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 1999;285(5434):1733-7.
DOI
|
17 |
국가암정보센터: 암통계, 2014.
|
18 |
Kalles V, Zografos GC, Provatopoulou X, Koulocheri D, Gounaris A. The current status of position emission mammography in brest cancer diagnosis. Breast Cancer 2013;20(2):123-30.
DOI
ScienceOn
|
19 |
이준성, 유동열. 건칠산 전탕액이 여성암 세포주에 미치는 영향. 대한한방부인과학회지 1997; 10(2):201-21.
|
20 |
안진영, 고성규, 고흥. 건칠(乾漆)이 위암세포의 활성, 세포사멸 및 세포주기관련 유전자 발현에 미치는 영향. 동의생리병리학회지 2006;20(3) :701-9.
|
21 |
윤성우, 박재우, 김경석, 정현식, 최원철. 건칠추출물(Nexia)의 독성 실험과 금성림프구성 백혈병환자의 임상증례군. 대한암한의학회지 2007;11(1) :1-21.
|
22 |
Coqueret O. New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment? Trends Cell Biol 2003;13(2):65-70.
DOI
|
23 |
Elledge SJ, Harper JW. Cdk inhibitors: on the threshold of checkpoints and development. Curr Opin Cell Biol 1994;6(6):847-52.
DOI
|
24 |
Lee JO, Moo JW, Kim SM, Kim N, Ko SG, Kim HS, et al. Rhus verniciflua extract modulates survival of MCF-7 breast cancer cells through the modulation of AMPK-pathway. Biol pharm Bull 2014;37(5):794-801.
DOI
|
25 |
최진영, 박재우, 김경석, 최원철, 윤성우. 알러젠 제거 옻나무추출물 투여로 호전된 편도선암 환자 1례. 대한암한의학회지 2007;12(1):91-7.
|
26 |
김초영, 박재우, 정현식, 최원철, 윤성우. 알러젠 제거 옻나무추출물 투여로 호전된 유방암 환자 1례. 대한암한의학회지 2007;12(1):67-73.
|